Tics & Tourette Syndrome
Tics & Tourette Syndrome
What Do You Need to Know?
- Tics are sudden, rapid, recurrent, non-rhythmic movements or vocalizations preceded by a premonitory urge and are temporarily suppressible
- Tourette syndrome: multiple motor tics + ≥1 vocal tic, onset <18 years, duration >1 year (DSM-5); male predominance 3–4:1. The most common initial tic is eye blinking (frequently tested board fact); motor tics typically precede vocal tics by 1–2 years.
- Tics wax and wane in severity, type, and location over time — this fluctuation is characteristic
- Comorbidities often more disabling than tics: ADHD (50–60%), OCD (40–60%), anxiety, depression
- CBIT is first-line behavioral treatment; alpha-2 agonists (guanfacine, clonidine) first-line pharmacologic
- Antipsychotics (fluphenazine, aripiprazole, pimozide) for severe/refractory tics — monitor QTc with pimozide
🚩 Don’t Miss — Test-Day Priorities
- Tourette DSM-5: ≥2 motor tics + ≥1 vocal/phonic tic (need not be concurrent), duration >1 year, onset before age 18
- Chronic (persistent) tic disorder: motor OR vocal tics (not both) >1 year; provisional tic disorder: <1 year duration
- Premonitory urge preceding the tic + temporary voluntary suppressibility with rebound = hallmark distinguishing tics from other hyperkinetic movements
- Tics wax and wane, worsen with stress/excitement/fatigue, improve with focused activity and sleep
- Coprolalia is rare (~10–15%) and NOT required for diagnosis — common board trap; eye blinking is the most common initial tic
- Comorbidities dominate the disease: ADHD ~50%, OCD ~50%, anxiety, depression, rage attacks — often more disabling than tics themselves; treat the most impairing condition first
- PANDAS = abrupt prepubertal onset of OCD/tics after Group A strep (check ASO, anti-DNase B); PANS = broader non-strep triggers
- Functional tic-like behaviors (rapid-onset adolescent females, COVID-era TikTok exposure surge): no premonitory urge, fixed/stereotyped, distractible, frequent complex coprolalia — do NOT respond to dopamine blockers
- First-line treatment: CBIT (Comprehensive Behavioral Intervention for Tics) including HRT (Habit Reversal Training) — Level A evidence
- First-line pharmacotherapy: α-2 agonists (guanfacine > clonidine) — especially when comorbid ADHD present; stimulants are NOT contraindicated in Tourette + ADHD despite the myth
- Refractory tics: antipsychotics (aripiprazole, risperidone, pimozide—ECG for QTc, haloperidol), VMAT2 inhibitors (tetrabenazine), botulinum toxin for focal tics, DBS (CM thalamus or GPi) for severe adult-refractory cases in expert centers — not FDA-approved for Tourette in the US (off-label/investigational)
🔍 Buzzwords & Pathognomonic FindingsClinical · Comorbidity / mimic · Treatment
Clinical phenotype
- Premonitory urge (“itch”/“pressure”) relieved by movement → tic
- Temporary voluntary suppressibility with rebound buildup → tic (vs chorea, myoclonus)
- Waxing-waning + worse with stress, better with focused activity → primary tic disorder
- ≥2 motor tics + ≥1 vocal tic, >1 year, onset <18 → Tourette syndrome (DSM-5)
- Eye blinking as first tic in a young boy → Tourette (3–4:1 male predominance)
- Coprolalia, echolalia, palilalia, echopraxia, copropraxia → complex tics
Comorbidities / mimics
- Abrupt prepubertal OCD/tics after sore throat + elevated ASO/anti-DNase B → PANDAS
- Same phenotype triggered by mycoplasma or viral infection (non-strep) → PANS
- Adolescent female, rapid-onset complex tics, no premonitory urge, TikTok exposure → functional tic-like behavior
- Fixed stereotyped pattern, distractible, female predominance, poor med response → functional tics
- “Just right” symmetry/ordering compulsions → Tourette-associated OCD (vs contamination-type primary OCD)
- Tics + chorea + lip/tongue self-mutilation + acanthocytes → neuroacanthocytosis
- Juvenile-onset tics evolving with chorea + family history → Huntington disease
- Adult-onset tics, no premonitory urge, no waxing/waning → secondary tics (stroke, TBI, encephalitis, drug-induced)
Treatment / pharmacology pearls
- CBIT / HRT (awareness + competing response training) → first-line behavioral therapy (Level A)
- Guanfacine, clonidine (α-2 agonists) → first-line pharmacotherapy, especially with comorbid ADHD
- Aripiprazole, risperidone, haloperidol, pimozide → antipsychotics for refractory tics (pimozide → QTc monitoring)
- Tetrabenazine, deutetrabenazine, valbenazine (VMAT2 inhibitors) → off-label severe tics (deutetra/valbenazine failed pediatric RCTs)
- Topiramate → adjunct with RCT support, weight-neutral option
- Botulinum toxin → focal motor/vocal tics — may reduce premonitory urge too
- DBS CM-Pf thalamus or GPi → severe treatment-refractory adult Tourette in expert multidisciplinary centers; in the US it is not an FDA-approved Tourette indication and is generally off-label/investigational
- SSRI + CBT for OCD; methylphenidate/stimulants for ADHD → treat comorbidities (stimulants generally tic-neutral — TACT trial)
Tic Classification
Definition & Key Features
- Premonitory urge: uncomfortable sensory phenomenon preceding the tic (“itch” or “pressure”) — present in >90% of patients ≥10 years
- Suppressibility: voluntarily suppressed for brief periods, but suppression builds urge (“rebound”)
- Suggestibility: tics may increase when discussed or observed
- Waxing and waning: severity fluctuates over weeks to months; types and locations change over time
- Exacerbating: stress, fatigue, anxiety, excitement — Improving: focused concentration, sleep
Tic Types
| Category | Description | Examples |
|---|---|---|
| Simple Motor | Brief, sudden, meaningless | Eye blinking (most common initial tic), facial grimacing, head jerking, shoulder shrugging |
| Complex Motor | Coordinated, purposeful-appearing | Touching objects, jumping, squatting, copropraxia (obscene gestures), echopraxia (imitating movements) |
| Simple Vocal | Meaningless sounds | Sniffing, throat clearing, grunting, barking, coughing |
| Complex Vocal | Linguistically meaningful | Coprolalia (obscene words — ~10–15% of Tourette), echolalia (repeating others’ words), palilalia (repeating own words) |
DSM-5 Tic Disorder Spectrum
- Provisional tic disorder: Motor and/or vocal tics, duration <1 year, onset <18 years
- Persistent (chronic) tic disorder: Motor OR vocal tics (not both), duration >1 year, onset <18 years
- Tourette syndrome: Multiple motor tics + ≥1 vocal tic (not necessarily concurrent), duration >1 year, onset <18 years
💎 Board Pearl
- Premonitory urge + suppressibility + waxing/waning = tics. The premonitory urge is the most distinguishing feature from other hyperkinetic movements.
- Coprolalia occurs in ~10–15% of Tourette patients — NOT required for diagnosis.
- Eye blinking is the most common initial tic. Motor tics typically precede vocal tics by 1–2 years.
Tourette Syndrome
Epidemiology & Genetics
- Prevalence: ~1% of school-age children; male:female = 3–4:1
- Age of onset: typically 4–6 years; peak severity: 10–12 years
- Natural history: ~75–90% experience substantial reduction in tic severity by adulthood; ~1/3 achieve near/complete remission, ~1/3 have mild residual tics, ~1/3 have persistent moderate-to-severe tics
- Genetics: Polygenic; MZ twin concordance 50–77%; SLITRK1 and HDC implicated in rare families
Pathophysiology
- Cortico-striato-thalamo-cortical (CSTC) circuit dysfunction — disinhibition of motor and limbic circuits
- Reduced caudate volume; dopamine hypothesis: hypersensitive striatal dopaminergic signaling — supported by response to D2 blockers
Diagnosis
- Clinical diagnosis — no confirmatory lab or imaging required
- DSM-5: Multiple motor + ≥1 vocal tic (need not be concurrent); >1 year duration; onset <18; not due to substance/medical condition
- YGTSS (Yale Global Tic Severity Scale): Standardized rating of tic number, frequency, intensity, complexity, interference
Clinical Pearl
- Motor and vocal tics do NOT need to occur simultaneously — both just need to have been present at some point during the illness.
- Tic severity does not predict comorbidity severity — mild tics may coexist with severely disabling OCD or ADHD.
Comorbidities
Comorbidities are the rule rather than the exception and are often more disabling than the tics themselves.
| Comorbidity | Prevalence | Key Points |
|---|---|---|
| ADHD | 50–60% | Most common; often appears before tics; stimulants generally safe; guanfacine treats both |
| OCD | 40–60% | “Just right” phenomena, symmetry, ordering > contamination; SSRIs + CBT first-line; may persist after tics remit |
| Anxiety | 30–40% | Generalized, social, separation anxiety; exacerbates tics |
| Depression | 20–25% | Primary or secondary to social stigma and functional impairment |
| Learning disabilities | 20–30% | Often related to comorbid ADHD/executive dysfunction rather than tics per se |
| Rage attacks | 25–70% | Explosive outbursts disproportionate to trigger; overlaps with ADHD impulsivity |
💎 Board Pearl
- Treat the most disabling condition first — often ADHD or OCD rather than tics.
- Stimulants are NOT contraindicated in Tourette — methylphenidate may mildly/transiently worsen tics but is generally safe.
- “Just right” OCD (symmetry, ordering) is more characteristic of Tourette-associated OCD than contamination-type.
Treatment
General Principles
- Not all tics require treatment — treat only if functionally impairing, painful, or causing significant distress
- Psychoeducation: Reassure about waxing/waning nature and likelihood of improvement with age
Behavioral Therapy (First-Line)
- CBIT (Comprehensive Behavioral Intervention for Tics): Gold-standard; includes HRT + function-based interventions + relaxation
- HRT (Habit Reversal Training): Awareness training (recognize premonitory urge) + competing response training (incompatible voluntary action)
- Level A evidence; comparable efficacy to medications without side effects; effective in children ≥9 years and adults
Pharmacotherapy
| Tier | Drug Class | Agents | Key Points |
|---|---|---|---|
| First-line | Alpha-2 agonists | Guanfacine, clonidine | Guanfacine preferred (less sedation); also treats ADHD; SE: sedation, hypotension |
| Second-line | Typical antipsychotics | Haloperidol (FDA-approved), pimozide (FDA-approved), fluphenazine (off-label) | Most potent tic suppressors; pimozide → QTc prolongation (ECG monitoring); fluphenazine sometimes preferred over haloperidol/pimozide due to lower reported EPS in observational data |
| Atypical antipsychotics | Aripiprazole (FDA-approved 2014, pediatric), risperidone (off-label) | Aripiprazole increasingly preferred (partial D2 agonist, favorable profile) | |
| Adjuncts | Other | Topiramate (off-label), tetrabenazine (off-label) | Topiramate has RCT support; tetrabenazine off-label for severe tics (risk of depression); deutetrabenazine (ARTISTS-1/2) and valbenazine failed to meet primary endpoints in pediatric Tourette RCTs — neither FDA-approved for tics |
| Focal tics | Botulinum toxin | OnabotulinumtoxinA | Focal motor or vocal tics; may reduce both the tic and premonitory urge in some patients; repeat q3–4 months |
| Refractory | Deep brain stimulation | CM-Pf thalamus (predominant modern target), GPi | Consider only for severe, treatment-refractory adult Tourette syndrome in expert multidisciplinary centers; ESTEL trial supports CM-Pf efficacy; in the US, DBS is NOT an FDA-approved Tourette indication and is generally off-label/investigational (FDA HDEs exist for OCD and historically dystonia, not Tourette) |
💎 Board Pearl
- CBIT/HRT is first-line for tics (Level A evidence). Always offer behavioral therapy before or alongside medications.
- Alpha-2 agonists (guanfacine > clonidine) are first-line pharmacotherapy — especially when comorbid ADHD is present.
- Pimozide requires ECG monitoring for QTc prolongation — contraindicated with CYP3A4 inhibitors.
- Botulinum toxin may reduce both the tic and premonitory urge in some patients — potential dual benefit for focal tics.
- TACT trial (Tourette Syndrome Study Group, Neurology 2002) — methylphenidate + clonidine combination effective and tic-neutral in children with tics + ADHD.
Secondary Tics
PANDAS / PANS
- PANDAS: Abrupt onset of OCD and/or tics following Group A strep; prepubertal; episodic course with strep-linked exacerbations; proposed mechanism involves molecular mimicry with anti–basal ganglia/anti-neuronal antibodies, though specific antibodies remain unvalidated and PANDAS as a distinct entity remains controversial
- PANS: Broader category — same phenotype, not limited to strep trigger (mycoplasma, viral, other immune)
- Treatment: Antibiotics for strep (prophylaxis debated); IVIG/plasmapheresis studied in severe cases with mixed/inconclusive RCT evidence (Williams 2016 IVIG trial negative for primary endpoint); standard tic/OCD medications
Drug-Induced Tics
- Stimulants: Methylphenidate, amphetamines — may unmask pre-existing tic tendency
- Cocaine, methamphetamine: Dopaminergic excess → tics and stereotypies
- Withdrawal tics: Sudden cessation of dopamine blockers (neuroleptic withdrawal-emergent tics)
Structural & Neurodegenerative
- Stroke or TBI involving basal ganglia or frontal cortex
- Huntington disease: Tics may be early feature, especially juvenile-onset HD
- Neuroacanthocytosis: Tics + chorea + lip/tongue biting; acanthocytes on smear
- Encephalitis: Post-encephalitic tics (viral, autoimmune including anti-NMDAR)
Clinical Pearl
- Abrupt explosive onset of tics + OCD in a prepubertal child after sore throat → PANDAS. Check ASO, anti-DNase B, throat culture.
- Consider secondary causes when tics are atypical: adult onset, sudden onset, no premonitory urge, associated neuro signs, or no waxing/waning.
Functional (Psychogenic) Tics
Rapid-onset functional tic-like behaviors surged 2020–2022, frequently associated with social media exposure (TikTok); predominantly adolescent females.
| Feature | Primary Tics (Tourette) | Functional Tic-Like Behaviors |
|---|---|---|
| Onset | Gradual, childhood (4–6 yr) | Abrupt, often adolescent/young adult |
| Premonitory urge | Present (>90%) | Typically absent |
| Suppressibility | Temporarily suppressible | No consistent suppressibility |
| Pattern | Waxes/wanes; type changes | Fixed, repetitive, stereotyped |
| Distraction | Tics may persist | Often resolve with distraction |
| Gender | Male predominance (3–4:1) | Female predominance |
| Coprolalia | ~10–15% | Frequently present; complex phrases |
| Response to tic meds | Yes | Poor or absent |
Management
- Positive diagnosis based on functional features — not a diagnosis of exclusion
- Treatment: Psychoeducation, CBT, physical therapy with motor retraining; avoid unnecessary dopamine blockers
💎 Board Pearl
- No premonitory urge + abrupt onset + fixed pattern + female predominance + distractibility = functional tic-like behavior.
- Functional tics do NOT respond to tic medications — dopamine blockers should be avoided.
References
- Robertson MM, Eapen V, Singer HS, et al. Gilles de la Tourette syndrome. Nat Rev Dis Primers. 2017;3:16097.
- Pringsheim T, Okun MS, Müller-Vahl K, et al. Practice guideline recommendations summary: treatment of tics in people with Tourette syndrome and chronic tic disorders. Neurology. 2019;92(19):896-906.
- Piacentini J, Woods DW, Scahill L, et al. Behavior therapy for children with Tourette disorder: a randomized controlled trial. JAMA. 2010;303(19):1929-1937.
- Leckman JF, Zhang H, Vitale A, et al. Course of tic severity in Tourette syndrome: the first two decades. Pediatrics. 1998;102(1):14-19.
- Swedo SE, Leonard HL, Garvey M, et al. Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections. Am J Psychiatry. 1998;155(2):264-271.
- Pringsheim T, Holler-Managan Y, Okun MS, et al. Comprehensive systematic review summary: treatment of tics in people with Tourette syndrome and chronic tic disorders. Neurology. 2019;92(19):907-915.
- Müller-Vahl KR, Sambrani T, Jakubovski E. Tic disorders revisited: introduction of the term “functional tic-like behaviors.” Mov Disord Clin Pract. 2022;9(8):1076-1084.
- Martino D, Pringsheim TM. Tourette syndrome and other chronic tic disorders: an update on clinical management. Expert Rev Neurother. 2018;18(2):125-137.
Continue reading — sign in
The full note has more clinical pearls, tables, and board-focused tips. Free account, no fee.